Tuberculin skin test: Operational research in the state of mato grosso do Sul, Brazil;Teste tuberculínico: Pesquisa operacional no mato grosso do sul

Jornal Brasileiro de Pneumologia

Volumn 37, Issue 5, 2011, Pages 646-654

  de Oliveira, Sandra Maria do Valle Leone ^a   Ruffino Netto, Antônio ^b   Paniago, Anamaria Mello Miranda ^c   de Oliveira, Olcinei Alves ^a   Marques, Marli ^d   da Cunha, Rivaldo Venâncio ^c   Andreotti, Renato ^e  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hélio Mandetta School of Medicine   (Brazil)

^d Mato Grosso do Sul State Health Department   (Brazil)

^e EMBRAPA CERRADOS   (Brazil)

Author keywords

Chemoprevention; Health services research; HIV; Latent tuberculosis; Tuberculin test

Indexed keywords

EID: 80155125150     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/s1806-37132011000500012     Document Type: Article

References (27)

1. Getahun H, Granich R, Sculier D, Gunneberg C, Blanc L, Nunn P, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010;24 Suppl 5:S57-65.
2. Cesar MC, Melo DA, Xavier GM, Salles C, Ruffino- Netto A. Prova tuberculínica cutânea. Pulmão RJ. 2003;12(3):116-27.
3. Carneiro AJ, Romão PA. A prova tuberculínica. Rev Bras Patol Clin. 1986;22(1):16-8.
4. Ruffino-Netto A. Prova tuberculínica. Rev Ass Med Brasil. 1979;25:257-9.
5. Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin Pde T, et al. III Brazilian Thoracic Association Guidelines on tuberculosis. J Bras Pneumol. 2009;35(10):1018-48.
6. Jamal LF, Moherdaui F. Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control [Article in Portuguese]. Rev Saude Publica. 2007;41 Suppl 1:104-10.
7. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de Controle da Tuberculose. Manual de Recomendações para o controle da Tuberculose no Brasil. Brasilia: Ministério da Saúde; 2010.
8. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1376-95.
9. Cengiz K, Seker A. Boosted tuberculin skin testing in hemodialysis patients. Am J Infect Control. 2006;34(6):383-7.
10. de Oliveira SM, Honner MR, Paniago AM, Aguiar ES, Venâncio da Cunha R. Prevalence of mycobacterium tuberculosis among professionals in a university hospital, Mato Grosso do Sul, 2004. Rev Lat Am Enfermagem. 2007;15(6):1120-4.
11. De Oliveira SM, Paniago AM, Bonecini-Almeida MG, Bertoni N, Stabile AC, Venâncio RV, et al. Tuberculin skin testing in HIV-infected patients in Campo Grande, Mato Grosso do Sul State, Brazil. J Venom Anim Toxins Incl Trop Dis. 2010;16(2):285-97.
12. Esteban J, Gadea I, Fernandez-Roblas R, Granizo JJ, Soriano F. Tuberculous infection in student nurses in Madrid, Spain. Int J Tuberc Lung Dis. 2001;5(6):583-4.
13. Miranda SS, Toledo AR, Ribeiro SR, Campos IM, Sthur PM, Kritski AL. Incidence of TB diagnosed in the emergency room of a teaching hospital in southeastern Brazil. J Bras Pneumol. 2009;35(2):174-8.
14. Lobue P, Menzies D. Treatment of latent tuberculosis infection: An update. Respirology. 2010;15(4):603-22.
15. Eldred LJ, Churchyard G, Durovni B, Godfrey-Faussett P, Grant AD, Getahun H, et al. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation. AIDS. 2010;24 Suppl 5:S1-3.
16. Lester R, Hamilton R, Charalambous S, Dwadwa T, Chandler C, Churchyard GJ, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS. 2010;24 Suppl 5:S45-8.
17. Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, King BS, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS. 2010;24 Suppl 5:S49-56.
18. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais. Boletim Epidemiológico AIDS 2010-Ano VII. Brasília: Ministério da Saúde; 2010.
19. Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. MMWR.1997;46(No. RR-15):1-13.
20. Nogueira CT, Abrantes J, Frauches D, Borges L. Abordagem profilática contra tuberculose em pacientes infectados pelo HIV em serviço ambulatorial de hospital filantrópico. DST - J Bras Doenças Sex Transm. 2009;21(4):158-62.
21. Villa TC, Ruffino-Neto A, editors. Tuberculose: pesquisas operacionais. Ribeirão Preto: FUNPEC; 2009.
22. Ruffino-Netto A. Epidemiologia da tuberculose - Estudo de alguns aspectos mensuráveis no teste tuberculínico [thesis]. Ribeirão Preto: Universidade de São Paulo; 1973.
23. Ruffino-Netto A, Kritski AL, Teixeira EG, Loredo CC, Souza DN, Trajman A. Influence of vial size on the results of the tuberculin test. J Bras Pneumol. 2005;31(2):144-8.
24. Ruffino-Netto A, Teruel, JR; Duarte, GG Análise dos erros nas leituras de provas tuberculínica I. Rev Serv Nac Tub. 1967;11:350-64.
25. Teruel JR, Netto AR, Duarte GG. Standardization of tuberculin test readers. Tubercle. 1969;50(4):350-5.
26. Almeida MC,Vinha VP, Ruffino-Netto A. Padronização de técnica de aplicação e leitura no teste tuberculínico. Medicina (Ribeirão Preto). 1973;6:23-30.
27. Lopes LK, Teles SA, Souza AC, Rabahi MF, Tipple AF. Tuberculosis risk among nursing professionals from Central Brazil. Am J Infect Control. 2008;36(2):148-51.